Next Article in Journal
Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals
Next Article in Special Issue
Venom Peptides as a Rich Source of Cav2.2 Channel Blockers
Previous Article in Journal
A Review of Thoracic Outlet Syndrome and the Possible Role of Botulinum Toxin in the Treatment of This Syndrome
Previous Article in Special Issue
Animal Toxins Can Alter the Function of Nav1.8 and Nav1.9
Toxins 2012, 4(11), 1236-1260; doi:10.3390/toxins4111236
Review

Conotoxins Targeting Neuronal Voltage-Gated Sodium Channel Subtypes: Potential Analgesics?

,
 and *
Received: 10 October 2012; in revised form: 5 November 2012 / Accepted: 5 November 2012 / Published: 8 November 2012
(This article belongs to the Special Issue Animal Toxins Targeting Ion Channels Involved in Pain)
View Full-Text   |   Download PDF [402 KB, updated 12 November 2012; original version uploaded 8 November 2012]   |   Browse Figures
Abstract: Voltage-gated sodium channels (VGSC) are the primary mediators of electrical signal amplification and propagation in excitable cells. VGSC subtypes are diverse, with different biophysical and pharmacological properties, and varied tissue distribution. Altered VGSC expression and/or increased VGSC activity in sensory neurons is characteristic of inflammatory and neuropathic pain states. Therefore, VGSC modulators could be used in prospective analgesic compounds. VGSCs have specific binding sites for four conotoxin families: μ-, μO-, δ- and ί-conotoxins. Various studies have identified that the binding site of these peptide toxins is restricted to well-defined areas or domains. To date, only the μ- and μO-family exhibit analgesic properties in animal pain models. This review will focus on conotoxins from the μ- and μO-families that act on neuronal VGSCs. Examples of how these conotoxins target various pharmacologically important neuronal ion channels, as well as potential problems with the development of drugs from conotoxins, will be discussed.
Keywords: voltage-gated sodium channel; Nav1.3; Nav1.7; Nav1.8; Nav1.9; m-conotoxin; mO-conotoxin; nociception; analgesic; pain voltage-gated sodium channel; Nav1.3; Nav1.7; Nav1.8; Nav1.9; m-conotoxin; mO-conotoxin; nociception; analgesic; pain
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Knapp, O.; McArthur, J.R.; Adams, D.J. Conotoxins Targeting Neuronal Voltage-Gated Sodium Channel Subtypes: Potential Analgesics? Toxins 2012, 4, 1236-1260.

AMA Style

Knapp O, McArthur JR, Adams DJ. Conotoxins Targeting Neuronal Voltage-Gated Sodium Channel Subtypes: Potential Analgesics? Toxins. 2012; 4(11):1236-1260.

Chicago/Turabian Style

Knapp, Oliver; McArthur, Jeffrey R.; Adams, David J. 2012. "Conotoxins Targeting Neuronal Voltage-Gated Sodium Channel Subtypes: Potential Analgesics?" Toxins 4, no. 11: 1236-1260.


Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert